Rivastigmine for alzheimer's disease: Canadian...

Rivastigmine for alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications

Jean-François Baladi, Peter A.B. Bailey, Sandra Black, Rémi W. Bouchard, Karl D. Farcnik, Serge Gauthier, Andrew Kertesz, Erich Mohr, Alain Robillard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Year:
2000
Language:
english
DOI:
10.1016/s0149-2918(00)83053-2
File:
PDF, 957 KB
english, 2000
Conversion to is in progress
Conversion to is failed